Repare Therapeutics Inc (RPTX)
3.24
-0.04
(-1.22%)
USD |
NASDAQ |
Nov 14, 16:00
3.24
0.00 (0.00%)
After-Hours: 20:00
Repare Therapeutics Total Liabilities (Quarterly): 31.67M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 31.67M |
| March 31, 2024 | 31.13M |
| December 31, 2023 | 41.82M |
| September 30, 2023 | 53.04M |
| June 30, 2023 | 56.17M |
| March 31, 2023 | 85.06M |
| December 31, 2022 | 84.56M |
| September 30, 2022 | 103.38M |
| June 30, 2022 | 82.53M |
| March 31, 2022 | 78.49M |
| Date | Value |
|---|---|
| December 31, 2021 | 80.29M |
| September 30, 2021 | 77.39M |
| June 30, 2021 | 75.56M |
| March 31, 2021 | 71.42M |
| December 31, 2020 | 70.26M |
| September 30, 2020 | 69.44M |
| June 30, 2020 | 68.08M |
| March 31, 2020 | 151.70M |
| December 31, 2019 | 148.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
31.13M
Minimum
Mar 2024
151.70M
Maximum
Mar 2020
76.88M
Average
75.56M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 161.36M |
| Edesa Biotech Inc | 2.361M |
| Lexaria Bioscience Corp | 0.2714M |
| InMed Pharmaceuticals Inc | 2.617M |
| Xenon Pharmaceuticals Inc | 39.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 235.34M |
| Shareholders Equity (Quarterly) | 203.68M |
| Current Ratio | 7.267 |